Cronos GroupSTU:7CI -2.68%84 Days Inventory is 166.04 as of Mar. 2026, which is 6% below its 10-year median of 176.31. GuruFocus rates STU:7CI with a GF Score™ of 84/100 and a GF Value™ of €3.09 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 919 Drug Manufacturers companies, Cronos Group ranks worse than 55.6% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Cronos Group's Average Total Inventories for the
three
months ended in Mar. 2026 was €41.0 Mil. Cronos Group's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €22.5 Mil.
Hence, Cronos Group's Days Inventory for the
three
months ended in Mar. 2026 was 166.04.
The historical rank and industry rank for Cronos Group's Days Inventory or its related term are showing as below:
STU:7CI'
s Days Inventory Range Over the Past 10 Years
Min: 122.17 Med: 176.31 Max: 1454.18
Current: 177.29
During the past 12 years, Cronos Group's highest Days Inventory was 1454.18. The lowest was 122.17. And the median was 176.31.
STU:7CI's Days Inventory is ranked worse than 55.6% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs STU:7CI: 177.29
Cronos Group's Days Inventory
declined
from Mar. 2025 (169.49) to Mar. 2026 (166.04).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Cronos Group's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.55.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cronos Group's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.05.
Cronos Group (STU:7CI) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Cronos Group's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cronos Group's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Cronos Group Days Inventory Related Terms
Cronos Group Days Inventory Historical Data
* Premium members only.
The historical data trend for Cronos Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cronos Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cronos Group Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cronos Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where Cronos Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cronos Group (STU:7CI) has a Days Inventory of 166.04 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cronos Group and its competitors. This is near median its historical median of 176.31. Over the past decade, Cronos Group's Days Inventory has ranged from 122.17 to 1,454.18. According to the industry distribution chart, Cronos Group ranks #511 out of 919 companies in the Drug Manufacturers industry, placing it in the top 55.6%.
Is Cronos Group's Days Inventory too high?
Cronos Group's current Days Inventory of 166.04 is near median its 10-year median of 176.31. Over the past 10 years, this metric has ranged from a low of 122.17 to a high of 1,454.18. The Drug Manufacturers industry median Days Inventory is 164.48. Cronos Group's value of 166.04 is 0.9% above this industry median. Based on the distribution chart, Cronos Group ranks #511 out of 919 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Cronos Group has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cronos Group's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cronos Group ranks #511 out of 919 companies for Days Inventory. This places Cronos Group in the lower half of its industry. The industry median Days Inventory is 164.48. Cronos Group's value of 166.04 is 0.9% above this benchmark. Historically, Cronos Group's own Days Inventory has ranged from 122.17 to 1,454.18 over the past decade. While the company's 10-year median is 176.31 vs. the industry median of 164.48, Cronos Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cronos Group's current Days Inventory of 166.04 is 0.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cronos Group and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cronos Group's current Days Inventory is 166.04, which is near median its own 10-year median of 176.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cronos Group stock overvalued right now?
Based on GuruFocus' analysis, Cronos Group (STU:7CI) is currently considered Modestly Undervalued. The stock's GF Value™ is €3.09, compared to a current price of €2.40 — trading 22.3% below its estimated fair value. The current Days Inventory is 166.04, which is near median its 10-year median of 176.31 and 0.9% above the Drug Manufacturers industry median of 164.48. Cronos Group's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Cronos Group (STU:7CI), the current Days Inventory is 166.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cronos Group (STU:7CI) Overvalued in 2026?
Based on GuruFocus' analysis, Cronos Group stock appears to be undervalued.
The current stock price of €2.40 is trading 22.3% below its estimated GF Value™ of €3.09.
GuruFocus considers Cronos Group to be Modestly Undervalued.
Key valuation signals for STU:7CI:
Days Inventory: 166.04 (near median its 10-year median of 176.31)
GF Value™: €3.09 vs. price of €2.40 (22.3% below fair value)
Industry Position: 0.9% above the Drug Manufacturers median (#511 of 919)
No single metric tells the full story. See the STU:7CI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
84GF Score
Get the complete analysis for STU:7CI
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:7CI has been successfully added to your 
